\begin{tabular}{lllll}
Rank & Score & Pair & Description & NN \\
\hline
\bfseries 1 & \bfseries 0.510 & \bfseries D00438 & \bfseries Nimodipine & 0.750 \\
\bfseries\indb{D,K}   &    & \bfseries hsa779 & \bfseries CACNA1S: calcium channel,&\\
     &&&\bfseries voltage-dependent, L type, alpha 1S subunit & 0.578 \\
\hline
 2 &  0.475 &  D00726 &  Metoclopramide & 0.200 \\
   &    &  hsa1138 &  CHRNA5: cholinergic receptor, nicotinic, alpha 5 & 0.443 \\
\hline
\bfseries 3 & \bfseries 0.459 & \bfseries D03365 & \bfseries Nicotine & 0.409 \\
\bfseries\indb{C,D}   &    & \bfseries hsa1137 & \bfseries CHRNA4: cholinergic receptor, nicotinic, alpha 4 & 0.528 \\
\hline
 4 &  0.399 &  D02098 &  Proparacaine hydrochloride & 0.667 \\
   &    &  hsa8645 &  KCNK5: potassium channel, subfamily K, member 5 & 0.013 \\
\hline
\bfseries 5 & \bfseries 0.385 & \bfseries D00552 & \bfseries Benzocaine & 0.579 \\
\bfseries\indb{K}   &    & \bfseries hsa6331 & \bfseries SCN5A: sodium channel, voltage-gated, type V, alpha subunit & 0.604 \\
\hline
 6 &  0.383 &  D00775 &  Riluzole & 0.000 \\
   &    &  hsa2898 &  GRIK2: glutamate receptor, ionotropic, kainate 2 & 0.811 \\
\hline
 7 &  0.382 &  D00294 &  Diazoxide & 0.175 \\
   &    &  hsa10060 &  ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9 & 0.682 \\
\hline
 8 &  0.367 &  D00477 &  Procainamide hydrochloride & 0.714 \\
   &    &  hsa6336 &  SCN10A: sodium channel, voltage-gated, type X, alpha subunit & 0.604 \\
\hline
 9 &  0.349 &  D00640 &  Propafenone hydrochloride & 0.457 \\
   &    &  hsa6336 &  SCN10A: sodium channel, voltage-gated, type X, alpha subunit & 0.604 \\
\hline
 10 &  0.336 &  D00524 &  Carbachol & 0.350 \\
   &    &  hsa1134 &  CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle) & 0.460 \\
\hline
\bfseries 11 & \bfseries 0.326 & \bfseries D00538 & \bfseries Zonisamide & 0.364 \\
\bfseries\indb{D,K}   &    & \bfseries hsa6331 & \bfseries SCN5A: sodium channel, voltage-gated, type V, alpha subunit & 0.604 \\
\hline
\bfseries 12 & \bfseries 0.319 & \bfseries D01969 & \bfseries Gallopamil hydrochloride & 0.865 \\
\bfseries\indb{K}   &    & \bfseries hsa778 & \bfseries CACNA1F: calcium channel,&\\
     &&&\bfseries voltage-dependent, L type, alpha 1F subunit & 0.561 \\
\hline
 13 &  0.318 &  D00547 &  Sevoflurane & 0.042 \\
   &    &  hsa2570 &  GABRR2 & 0.683 \\
\hline
 14 &  0.313 &  D00349 &  Isradipine & 0.733 \\
   &    &  hsa773 &  CACNA1A: calcium channel,&\\
     &&& voltage-dependent, P/Q type, alpha 1A subunit & 0.285 \\
\hline
 15 &  0.313 &  D00524 &  Carbachol & 0.350 \\
   &    &  hsa1139 &  CHRNA7: cholinergic receptor, nicotinic, alpha 7 & 0.356 \\
\hline
\bfseries 16 & \bfseries 0.307 & \bfseries D03830 & \bfseries Diltiazem malate & 0.358 \\
\bfseries\indb{K}   &    & \bfseries hsa776 & \bfseries CACNA1D: calcium channel,&\\
     &&&\bfseries voltage-dependent, L type, alpha 1D subunit & 0.641 \\
\hline
 17 &  0.301 &  D00799 &  Trifluoperazine hydrochloride & 0.879 \\
   &    &  hsa3782 &  KCNN3: potassium intermediate/small&\\
     &&& conductance calcium-activated channel, subfamily N, member 3 & 0.630 \\
\hline
\bfseries 18 & \bfseries 0.292 & \bfseries D00616 & \bfseries Diltiazem hydrochloride & 0.404 \\
\bfseries\indb{K}   &    & \bfseries hsa776 & \bfseries CACNA1D: calcium channel,&\\
     &&&\bfseries voltage-dependent, L type, alpha 1D subunit & 0.641 \\
\hline
 19 &  0.287 &  D00136 &  Haloperidol & 0.303 \\
   &    &  hsa116443 &  GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A & 0.443 \\
\hline
\bfseries 20 & \bfseries 0.284 & \bfseries D00283 & \bfseries Clozapine & 0.371 \\
\bfseries\indb{C}   &    & \bfseries hsa170572 & \bfseries HTR3C & 0.738 \\
\hline
\end{tabular}
